Belfius Bank SA (A2R907) News

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]